These findings indicate that dysregulated turnover of versican and decorin alters levels of these proteoglycans in the lung ECM, a process that may be partially responsible for fibrotic manifestations of IPF, IIP, and COPD. This evidence concerns the gene DCN and idiopathic interstitial pneumonia.